4//SEC Filing
Bamforth Mark R 4
Accession 0001225208-09-013014
CIK 0000732485other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 1:31 PM ET
Size
7.6 KB
Accession
0001225208-09-013014
Insider Transaction Report
Form 4
GENZYME CORPGENZ
Bamforth Mark R
Sr.VP, Corp. Operations & Phar
Transactions
- Award
Restricted Stock Units
2009-05-21+4,750→ 4,750 totalExercise: $0.00From: 2012-05-21→ Genzyme common stock (GENZ) (4,750 underlying) - Award
Stock Option (right to buy)
2009-05-21+14,250→ 14,250 totalExercise: $58.66From: 2009-05-21Exp: 2019-05-21→ Genzyme common stock (GENZ) (14,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Genzyme common stock.
- [F2]The restricted stock units vest 100% on the 3rd anniversary of the date of grant.
- [F3]Options vest in 20% annual increments beginning on the original date of grant.
Documents
Issuer
GENZYME CORP
CIK 0000732485
Entity typeother
Related Parties
1- filerCIK 0001435745
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 1:31 PM ET
- Size
- 7.6 KB